RLX Technology Reports 2022 Fiscal Year Financial Performance

Mar.10.2023
RLX Technology Reports 2022 Fiscal Year Financial Performance
RLX Technology released unaudited financial results showing a year-on-year decline in revenue and profit for 2022.

On March 10th, RLX Technology, also known as Yuè Kè, announced its unaudited financial results for the year ended December 31st, 2022, and its Q4 financial results on the NASDAQ website. The company's consolidated financial report showed that its net revenue for the full year of 2022 was RMB 5.33 billion, a 37.41% decrease compared to RMB 8.52 billion in 2021. Its net profit for 2022 was RMB 1.409 billion, compared to RMB 2.028 billion in 2021.


Financial summary for the fourth quarter of 2022.


The net revenue for the fiscal year 2022 was 340 million yuan (49.3 million USD), which is a decrease of 82.14% compared to the same period in 2021, where it was 1.9044 billion yuan. The gross profit margin for the year was 43.6%, compared to last year's 40.2%. The net loss under US GAAP was 225.1 million yuan (32.6 million USD), while last year's net profit under US GAAP was 494.4 million yuan. The non-US GAAP net income for the year was 249.7 million yuan (36.2 million USD), compared to last year's 536.5 million yuan. This is a summary of the financial results for the fiscal year 2022.


In the fiscal year of 2022, the net revenue for the company was 53.328 billion Yuan (7.732 billion USD), a decrease from the previous year's revenue of 85.210 billion Yuan. The gross profit margin for 2022 was 43.2%, slightly higher than the previous year's margin of 43.1%. Under the Generally Accepted Accounting Principles in the United States, the net revenue for 2022 was 14.087 billion Yuan (2.042 billion USD), down from the previous year's revenue of 20.281 billion Yuan. The non-US GAAP net revenue for 2022 was 15.749 billion Yuan (2.283 billion USD), a decrease from the previous year's revenue of 22.515 billion Yuan.


References:


RLX Technology has released its financial results for the fourth quarter and fiscal year 2022, which have not been audited.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
Product | Labeled “Built in the USA” Up to 60,000 Puffs: DOJO PUREX 60K Launches on U.S. Sales Channels
Product | Labeled “Built in the USA” Up to 60,000 Puffs: DOJO PUREX 60K Launches on U.S. Sales Channels
DOJO unveiled the PUREX 60K e-cigarette at TPE 2026 held in Las Vegas, United States. The product is labeled “Built in the USA,” supports up to 60,000 puffs, and features 16ml e-liquid capacity, a 1000mAh battery, and ECO and SMART output modes. It has gone live on DOJO’s official website and select U.S. online sales channels at a price of $18.99.
Apr.07 by 2FIRSTS.ai
South Dakota Legislature Approves Two Nicotine Licensing Bills Pending Governor’s Decision
South Dakota Legislature Approves Two Nicotine Licensing Bills Pending Governor’s Decision
The South Dakota Legislature gave final approval on Tuesday to two proposals requiring state licenses for businesses that sell nicotine products. Under the bills, wholesalers, distributors and retailers of nicotine products in the state would need to be licensed by the government.
Mar.12 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
The Philippine Department of Health reiterated Saturday that vaping should not be promoted as an alternative to cigarette smoking, Health Secretary Teodoro “Ted” Herbosa said in a radio interview, according to the Tribune. Herbosa said both vaping and smoking pose irreversible health risks and cited E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI), claiming it led to the death of a 22-year-old male with no smoking history in 2025.
Feb.28 by 2FIRSTS.ai